A Potent Micron Neoantigen Tumor Vaccine GP‐Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models

Abstract Therapeutic tumor neoantigen vaccines have been widely studied given their good safety profile and ability to avoid central thymic tolerance. However, targeting antigen‐presenting cells (APCs) and inducing robust neoantigen‐specific cellular immunity remain challenges. Here, a safe and broa...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Zhe Jing, Shuqing Wang, Keyuan Xu, Qian Tang, Wenjing Li, Wei Zheng, Haobo Shi, Kailing Su, Yanting Liu, Zhangyong Hong
Materialtyp: Artikel
Språk:English
Publicerad: Wiley 2022-08-01
Serie:Advanced Science
Ämnen:
Länkar:https://doi.org/10.1002/advs.202201496